Cargando…

Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture

OBJECTIVES: Tumours can be categorised based on their stromal architecture into tumour vessel and stromal vessel phenotypes, and the phenotypes have been suggested to define tumour response to chronic treatment with a VEGFR2 antibody. However, it is unclear whether the vascular phenotypes of tumours...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yanyan, Allen, Danny, Kersemans, Veerle, Devery, Aoife M., Bokobza, Sivan M., Smart, Sean, Ryan, Anderson J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641245/ https://www.ncbi.nlm.nih.gov/pubmed/26323213 http://dx.doi.org/10.1016/j.lungcan.2015.08.009

Ejemplares similares

Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer
por: DEVERY, AOIFE M., et al.
Publicado: (2015)

Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality
por: Jiang, Yanyan, et al.
Publicado: (2016)

Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells
por: Bokobza, Sivan M., et al.
Publicado: (2014)

Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer
por: Weber, Anika Maria, et al.
Publicado: (2016)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours()()
por: Knight, James C., et al.
Publicado: (2019)

RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib
por: Bradford, James R., et al.
Publicado: (2013)

Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts
por: Kersemans, Veerle, et al.
Publicado: (2015)

MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2017)

Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer
por: Gopinathan, Ganga, et al.
Publicado: (2022)

Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
por: Kersemans, Veerle, et al.
Publicado: (2010)

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
por: Brown, Nicholas, et al.
Publicado: (2016)

A simple, open and extensible gating Control unit for cardiac and respiratory synchronisation control in small animal MRI and demonstration of its robust performance in steady-state maintained CINE-MRI
por: Gilchrist, Stuart, et al.
Publicado: (2021)

Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
por: Torres, Julia Baguña, et al.
Publicado: (2017)

A System-Agnostic, Adaptable and Extensible Animal Support Cradle System for Cardio-Respiratory-Synchronised, and Other, Multi-Modal Imaging of Small Animals
por: Kersemans, Veerle, et al.
Publicado: (2021)

An MRI-Compatible High Frequency AC Resistive Heating System for Homeothermic Maintenance in Small Animals
por: Gilchrist, Stuart, et al.
Publicado: (2016)

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
por: Sahebjam, S, et al.
Publicado: (2013)

A resistive heating system for homeothermic maintenance in small animals
por: Kersemans, Veerle, et al.
Publicado: (2015)

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
por: Nguyen, James, et al.
Publicado: (2023)

(111)In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin
por: Cornelissen, Bart, et al.
Publicado: (2012)

Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy
por: Spencer, S K M, et al.
Publicado: (2013)

Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma
por: Lobo, Merryl R., et al.
Publicado: (2015)

Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice
por: Macioszek, Szymon, et al.
Publicado: (2023)

Vascular permeability in a human tumour xenograft: molecular charge dependence
por: Dellian, M, et al.
Publicado: (2000)

Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models
por: Kaeppler, Jakob R, et al.
Publicado: (2022)

Reduced respiratory motion artefact in constant TR multi-slice MRI of the mouse
por: Kinchesh, Paul, et al.
Publicado: (2019)

Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling
por: Knight, James C., et al.
Publicado: (2020)

Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation
por: Lobo, Merryl R., et al.
Publicado: (2014)

Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray
por: Jiang, Wenhua, et al.
Publicado: (2017)

Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.
por: Wist, E., et al.
Publicado: (1981)

MRI measurements of vessel calibre in tumour xenografts: Comparison with vascular corrosion casting
por: Burrell, Jake S., et al.
Publicado: (2012)

Long-term Remission Over Six Years for a Patient with Recurrent Glioblastoma Treated with Cediranib/Lomustine
por: Drazin, Doniel, et al.
Publicado: (2016)

Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial
por: Stark, Dan P., et al.
Publicado: (2017)

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
por: Bi, Jianling, et al.
Publicado: (2021)

Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
por: Thomas, Eloise, et al.
Publicado: (2019)

Olaparib increases the therapeutic index of hemithoracic irradiation compared with hemithoracic irradiation alone in a mouse lung cancer model
por: Jiang, Yanyan, et al.
Publicado: (2021)

A Carbon-Fiber Sheet Resistor for MR-, CT-, SPECT-, and PET-Compatible Temperature Maintenance in Small Animals
por: Kersemans, Veerle, et al.
Publicado: (2019)

Improved detection of molecularly targeted iron oxide particles in mouse brain using B(0) field stabilised high resolution MRI
por: Gilchrist, Stuart, et al.
Publicado: (2020)

Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013)

Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation
por: Kim, Joseph W., et al.
Publicado: (2021)

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
por: Kim, Joseph W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mcf00r5o5rsusaj3qlfi58vgdj